Interhospital referral of colorectal cancer patients: a Dutch population-based study

Abstract

Purpose: Interhospital referral is a consequence of centralization of complex oncological care but might negatively impact waiting time, a quality indicator in the Netherlands. This study aims to evaluate characteristics and waiting times of patients with primary colorectal cancer who are referred between hospitals.

Methods: Data were extracted from the Dutch ColoRectal Audit (2015-2019). Waiting time between first tumor-positive biopsy until first treatment was compared between subgroups stratified for referral status, disease stage, and type of hospital.

Results: In total, 46,561 patients were included. Patients treated for colon or rectal cancer in secondary care hospitals were referred in 12.2% and 14.7%, respectively. In tertiary care hospitals, corresponding referral rates were 43.8% and 66.4%. Referred patients in tertiary care hospitals were younger, but had a more advanced disease stage, and underwent more often multivisceral resection and simultaneous metastasectomy than non-referred patients in secondary care hospitals (p<0.001). Referred patients were more often treated within national quality standards for waiting time compared to non-referred patients (p<0.001). For referred patients, longer waiting times prior to MDT were observed compared to non-referred patients within each hospital type, although most time was spent post-MDT.

Conclusion: A large proportion of colorectal cancer patients that are treated in tertiary care hospitals are referred from another hospital but mostly treated within standards for waiting time. These patients are younger but often have a more advanced disease. This suggests that these patients are willing to travel more but also reflects successful centralization of complex oncological patients in the Netherlands.

Keywords: Centralization; Colorectal cancer care; Interhospital referral; Waiting time.

Fig. 1

a Waiting times in days for colon cancer patients. Figure 1 a shows the waiting time (days) for NRF and RF colon cancer patients in secondary and tertiary hospitals. A Chi-square test was used. Group 1, T1-3N0-2M0; group 2, T4N0-2M0; group3, M1. b Waiting times in days for rectal cancer patients. Figure 1 b shows the waiting time (days) for NRF and RF rectal cancer patients in secondary and tertiary hospitals. A Chi-square test was used. Group 1, T1-3N0-2M0; group 2, T4N0-2M0; group3, M1

Fig. 2

Waiting times for biopsy until MDT and MDT until treatment. Figure 2 shows the waiting times (weeks) for biopsy until MDT and MDT until treatment for NRF and RF patient in secondary and tertiary hospitals